Earlier this month, ActivMed announced it is now joining this Phase III study for a potential vaccine against COVID-19. There are currently no available vaccines in the U.S., and safe and effective ones would have a significant public health impact. Further testing is needed through clinical research studies, but every day we edge closer to FDA approval and availability to the public. In the meantime, we must be diligent about following the CDCs’ recommendations for protecting ourselves. November is also National Healthy Skin Month, and nothing goes better with COVID-19 prevention measures than good hygiene.
National Healthy Skin Month
November is National Healthy Skin Month, and it’s fitting the body’s largest organ, the skin, gets some well-deserved attention. Your skin plays a vital role in your overall health by acting as a protective barrier against harmful things in the environment and keeps moisture in. It helps us feel different sensations and protects us from the heat and cold.
To keep your skin functioning as it should, you need to take care of it. Practice good hygiene by cleaning it regularly, wash hands before eating and after being in public, and see a dermatologist if any skin issues persist. Moisturize daily, protect your skin from the sun with sunscreen while outside, and hydrate throughout every day. View more tips from AAD here.
COVID-19 Vaccine- What You Need to Know
While the news of Pfizer and Moderna’s vaccine effectiveness is promising, there are still steps we need to take before the entire public has access to a safe and effective vaccine. Also, these two aren’t the only vaccines in development and testing. Furthermore, additional time is needed to understand the long-term immunity and effects.
There are currently 236 vaccines in development, and around 40 are being tested in clinical research studies. Typically, vaccines take years to develop and test. However, thanks to programs like Operation Warp Speed and FDA fast-tracking, COVID-19 vaccines and treatments get priority and move quickly through the process. Developers in the later stages of research can apply for emergency authorization use, which would make them available sooner if approved by the FDA.
Even if granted, until the vaccines’ manufacturing ramps up, they will be released in smaller quantities, giving vulnerable populations like the elderly or those at high risk of severe complications from COVID priority. Those that remain would see availability open a few months later.
Join the Fight with ActivMed
“Our team at ActivMed looks forward to helping bring a vaccine against COVID-19 and a hopeful end to the pandemic. We hope you will help as we are looking for trial participants. We are trying to provide as safe an environment as possible. We are following CDC recommendations for participant safety. It is through this collaboration that we will be able to conduct this monumental endeavor. Looking forward to seeing you in our Portsmouth, N.H. site!”- Principal Investigator Michael J. McCartney, M.D. and Chief Medical Director at ActivMed.
Are you ready to join the fight against COVID-19? Get started today by visiting our website to learn more about the COVID-19 studies enrolling at our Portsmouth, NH location.
References: